This test is most useful if any of these apply to you.
Hereditary hemochromatosis can make your gut absorb more iron than you need. Over time, excess iron can damage your liver, pancreas, joints, and sometimes your heart. This panel checks three inherited variants in HFE. HFE is a gene that helps control iron absorption. Finding a variant can identify susceptibility before symptoms develop, but it doesn't establish that iron has accumulated.
The combination matters. Two copies of C282Y carry a much stronger risk than one copy paired with H63D or S65C. Reading the genetic results alongside your iron studies helps distinguish a tendency that needs monitoring from iron overload that may need treatment.
The HFE protein helps regulate hepcidin production. Hepcidin is a liver hormone that limits iron absorption. Two C282Y copies can disrupt this control and account for most HFE-related hemochromatosis in people of Northern European ancestry. Many people with this genetic pattern never develop organ damage.
H63D has a weaker association with iron abnormalities. In an Australian population study, it was associated with higher transferrin saturation without a corresponding rise in average ferritin. One C282Y plus one H63D can accompany mild iron loading, but substantial overload is uncommon. Alcohol-related liver disease, fatty liver, and other genetic factors can affect how the pattern develops.
S65C adds information about another HFE variant. Small human studies have reported mild or moderate iron loading in some people carrying it, but its role in clinically significant disease remains unestablished. C282Y testing has an established diagnostic role; the evidence does not support treating all three variants as equivalent causes of disease. Specialist genetic guidelines do not recommend S65C as a routine diagnostic target.
Ferritin helps estimate your stored iron. Transferrin saturation measures how much of your blood's iron-carrying capacity is occupied. These are separate blood measurements, not results included in this DNA panel. Interpret the full variant pattern with both.
| Your results | What the pattern suggests |
|---|---|
| Two C282Y copies with normal ferritin | Inherited susceptibility with no ferritin elevation yet. High transferrin saturation can appear before ferritin rises. |
| Two C282Y copies with persistently high transferrin saturation and raised ferritin | The typical laboratory pattern of HFE-related hemochromatosis. It supports assessment of iron overload and liver health. |
| One C282Y plus one H63D with raised iron measurements | Possible mild iron loading. Substantial overload needs assessment for additional causes and, when appropriate, confirmation of liver iron. |
| One C282Y plus one S65C | A possible mild iron-loading association with less certain clinical significance. Ferritin and transferrin saturation determine whether an iron abnormality is present. |
| A single variant, or H63D without C282Y, with high ferritin | This genetic result alone usually doesn't explain substantial iron overload. Other causes of high ferritin need consideration. |
| High ferritin with normal transferrin saturation, whatever your genetic result | Inflammation, fatty liver, or alcohol-related injury may explain the ferritin. Some less common forms of iron overload also have this pattern. |
| None of the three variants detected, but iron measurements stay high | The common C282Y-related cause is unlikely. Acquired iron overload and rarer inherited causes remain possible. |
Risk also depends on age and sex. In a Melbourne cohort followed for about 12 years, documented iron-related disease was present in about 28% of men with two C282Y copies and about 1% of women. The definition included raised liver enzymes and characteristic joint findings as well as severe liver disease. Menstrual blood loss partly explains the sex difference, and iron stores can rise after menopause.
Later-life risks are substantial in some people. A British population study estimated that about one in five men with two C282Y copies would have a liver disease diagnosis by age 80, compared with about one in twelve men carrying neither C282Y nor H63D. A separate analysis estimated primary liver cancer risk by age 75 at about 7% versus less than 1%. These are population estimates, not predictions of your outcome after diagnosis and treatment.
A Danish study also found higher diabetes risk among people with two C282Y copies whose ferritin and transferrin saturation were normal at a single measurement. That association doesn't establish that blood removal benefits people whose iron stores are normal.
Use your genetic result to guide assessment of your iron measurements and family history. Confirmed iron overload may call for supervised blood removal and assessment of liver scarring. Treatment decisions for H63D or S65C combinations require evidence of excess iron; the genetic label alone is insufficient. Adult close relatives of someone with confirmed HFE-related hemochromatosis can benefit from family testing.
Alcohol intake and abdominal fat also affect liver risk. Among men with two C282Y copies, one study estimated liver scarring by age 80 in about 15% with a high waist-to-hip ratio versus about 4% with a normal ratio. This was an observational association, not a trial of weight loss.
Ferritin can rise with inflammation, recent illness, fatty liver, or alcohol-related injury, sometimes without excess tissue iron. Those conditions can also coexist with inherited iron overload. Avoid assuming that a mild genetic finding explains every abnormal iron result.
A negative result covers only the variants tested. This panel does not examine every HFE variant or other iron-regulating genes. Its ability to identify an inherited cause varies with ancestry because C282Y is much more common in Northern European populations.
Hereditary Hemochromatosis DNA Mutation Analysis is best interpreted alongside these tests.